XCAM is UK’s “Most Innovative” Life Science Company
Surprisingly XCAM didn’t start life in the field of biological research but was a spin-out from the world class X-ray Astronomy group at the University of Leicester. Now, however, the expertise that XCAM has developed from X-ray Astronomy allows it to provide vital customised camera equipment to some of the most advanced life science research in the world, which gives much clearer images of atomic-level structures such as viruses and proteins. Such detailed imagery is generating a greater worldwide knowledge of how potentially deadly viruses might be understood and managed.
The company is based near Northampton, and specialises in the design and manufacture of advanced camera systems which use charge-coupled device technology (CCD).The skills that XCAM has developed from X-ray astronomy have proved useful in a range of applications but the potential life sciences applications are wide ranging.
XCAM CEO Karen Holland says, “Whilst we began many years ago as a small company selling just a sensor controller, we began to recognise that our expertise, gained through working on varied interesting projects could be applied commercially to bioscience research. We researched the opportunities and decided to take the bioscience development further, a decision that has lead to this award. The greatest accolade is always to be recognised by your peers for what you do. Winning the Innovation prize at these national awards, which are held in high regard across the Life Sciences industry, means that the work we are doing is recognised within the industry as being at the leading technological edge in our field. Our cameras are being used in major areas of new life science research. For instance, we have supplied cameras to the XFEL (X-ray free electron lasers) experiment at Deutsches Elektronen Synchrotron (DESY) in Germany where they were used to take world-lead ing images of the giant Mimivirus, and we were involved in developing the specification for a unique detector that is now used at the Japanese XFEL facility at SPring-8 for similar applications. Better understanding of the Mimivirus structure will result in a leap forward in the development of future antivirus products and subsequent healthcare.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.